Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lakshmanan

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of Clinical Endocrinology and Metabolism|March 20, 1999
Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinomaS S Koong, J C Reynolds, E G Movius, et al.
The Lancet. Diabetes & Endocrinology|September 30, 2018
GLP-1 receptor agonists, CKD, and eGFR trajectory - Authors' replyKatherine R Tuttle, Mark C Lakshmanan, Brian Rayner, et al.
The Lancet. Diabetes & Endocrinology|June 19, 2018
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trialKatherine R Tuttle, Mark C Lakshmanan, Brian Rayner, et al.
Journal of Women'S Health & Gender-Based Medicine|November 24, 1999
Healthcare use among U.S. women aged 45 and older: total costs and costs for selected postmenopausal health risksT J Hoerger, K E Downs, M C Lakshmanan, et al.
Cardiovascular Diabetology|September 26, 2021
Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWINDManige Konig, Matthew C Riddle, Helen M Colhoun, et al.
Diabetes, Obesity & Metabolism|February 5, 2019
Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United StatesKristina S Boye, Matthew C Riddle, Hertzel C Gerstein, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 15, 2009
Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fracturesPer Aspenberg, Harry K Genant, Torsten Johansson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 14, 2011
The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fracturesP Hadji, J R Zanchetta, L Russo, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Clinical Endocrinology and Metabolism|March 20, 1999
Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinomaS S Koong, J C Reynolds, E G Movius, et al.
The Lancet. Diabetes & Endocrinology|September 30, 2018
GLP-1 receptor agonists, CKD, and eGFR trajectory - Authors' replyKatherine R Tuttle, Mark C Lakshmanan, Brian Rayner, et al.
The Lancet. Diabetes & Endocrinology|June 19, 2018
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trialKatherine R Tuttle, Mark C Lakshmanan, Brian Rayner, et al.
Journal of Women'S Health & Gender-Based Medicine|November 24, 1999
Healthcare use among U.S. women aged 45 and older: total costs and costs for selected postmenopausal health risksT J Hoerger, K E Downs, M C Lakshmanan, et al.
Cardiovascular Diabetology|September 26, 2021
Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWINDManige Konig, Matthew C Riddle, Helen M Colhoun, et al.
Diabetes, Obesity & Metabolism|February 5, 2019
Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United StatesKristina S Boye, Matthew C Riddle, Hertzel C Gerstein, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 15, 2009
Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fracturesPer Aspenberg, Harry K Genant, Torsten Johansson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 14, 2011
The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fracturesP Hadji, J R Zanchetta, L Russo, et al.
Pageof 3